The current rapid spread of the novel coronavirus (2019-nCoV) originating from Wuhan, China, calls for a rapid response from the research community. Lithium is widely used to treat bipolar disorder, but has been shown to exhibit antiviral activity. This brief review took a systematic approach to identify five studies reporting on the influence of lithium in vitro on coronaviral infections. We propose that in the case of urgent need, lithium be explored as a potential treatment or prophylaxis for the novel Wuhan coronavirus (2019-nCoV).
Introduction
The current rapid spread of the novel coronavirus (2019-nCoV) originating from Wuhan, China, calls for a rapid response from the research community. Lithium is known to exhibit antiviral activity, but the knowledge of its potential as a possible therapy for coronoviral infections has not been summarized yet. The aim of this brief report is to draw attention to lithium as potential 2019-nCoV treatment and prophylaxis.
Methods
On February 1 st 2020 the following PubMed search was conducted with no language or time restrictions: (lithium and (coronavirus or *coronavirus or sarbecovirus or SARS or "severe acute respiratory syndrome" or MERS or "Middle East respiratory syndrome" or nobecovirus or merbecovirus or hibecovirus or embecovirus or andecovirus or buldecovirus or herdecovirus or moordecovirus or cegacovirus or igacovirus or "microhyla lentovirus" or milecovirus or alphaletovirus or tegacovirus or setracovirus or rhinacovirus or pedacovirus or "porcine epidemic diarrhea" or nyctacovirus or "nectalus velutinus" or myotacovirus or "myotis ricketti" or minunacovirus or minacovirus or luchacovirus or duvinacovirus or decacovirus or "Rhinolophus ferrumequinum" or "transmissible gastroenteritis virus" or "feline infectious peritonitis virus" or "canine coronavirus" or "murine hepatitis virus")). The search yielded 45 articles, of which all the abstracts were charted and reviewed by two researchers.
Results
Five studies reporting on the influence of lithium on coronaviral infections were identified ( Figure 1 ).
In Vero cells, lithium chloride was shown to be effective in suppressing infection with the porcine epidemic diarrhea virus (PEDV), a member of the Coronaviridae family 1 . Not only PEDV entry and replication were inhibited in the presence of LiCl, but apoptosis as well. In MARC-145 cells, LiCl reduced the production of RNA and proteins specific to the porcine reproductive and respiratory syndrome virus. The authors, however, cautioned that the effect might have been dependent on LiCl presence during the early stages of infection and the increase of tumor necrosis factor-α 2 . In vitro studies of another porcine coronavirus causing transmissible gastroenteritis indicated that LiCl acts on both early and late stages of infection and inhibits apoptosis 3 . The same research group from Harbin in China reported earlier that LiCl reduced the cytopathic effect of the avian infectious bronchitis virus (also a coronavirus) in primary chicken embryo kidney cells 4 . In Vero cells, African green monkey kidney-derived epithelial cells, and immortalized chicken embryo fibroblasts LiCl suppressed the avian coronavirus infectious bronchitis. The antiviral activity of lithium was ascribed to a cellular effect 5 .
Discussion
The possible molecular mechanisms of reduced apoptosis include the inhibition of glycogen synthase kinase 3-beta (GSK-3β) 6,7 . Moreover, PEDV requires the PI3K/Akt/GSK-3α/β pathway, which can be targeted at GSK-3β by lithium 8 . Curiously, GSK-3β is required for template switching, a process seemingly indispensable for the production of coronaviral genomic RNA. The inhibition of GSK-3β prevents longer viral subgenomic mRNAs and the genomic RNA from being synthesized 9 . Their production would require GSK-3β-dependent phosphorylation of the viral nucleocapsid and subsequent recruitment of helicase DDX1.
Lithium carbonate is an orphan drug widely used in the treatment of bipolar disorder. Its safety, when used correctly, is excellent 10 . The main concern in the setting of an infectious disease unit would be the potential for interactions with other medication, possibly leading to the elevation of lithium levels and acute toxicity, mostly renal. This may be prevented by monitoring serum lithium concentrations. To our best knowledge, no interactions between lithium carbonate and ribavirin, lopinavir or ritonavir exist. In unconscious patients lithium carbonate could be given via a nasogastric tube. In case of lithium carbonate unavailability, lithium orotate could be explored, which, however, remains much less known to medical science despite being available as a dietary supplement. Overall, we propose that in the case of urgent need lithium be explored by physicians as a potential treatment or prophylaxis for the novel Wuhan coronavirus (2019-nCoV).
Data availability
Underlying data All data underlying the results are available as part of the article and no additional source data are required.
Reporting guidelines
Zenodo: PRISMA ScR checklist for 'Is lithium a potential treatment for the novel Wuhan (2019-nCoV) coronavirus? A scoping review'. https://doi.org/10.5281/zenodo.3637574 11 .
The adapted reporting guidelines checklist is available under the terms of the Creative Commons Attribution 4.0 International license (CC-BY 4.0).
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With the current epidemic being so severe, it is necessary and urgent to make potentially reasonable recommendations for the treatment or prevention for 2019-nCoV or NCP. The two authors clearly proposed that lithium might be a potential treatment or prophylaxis for 2019-nCoV or NCP based on a summary of existing literature that reported the effects of lithium on coronaviral infections and in vitro discussed potential mechanisms, which sound reasonable to some extent, but still not rigorous.
Specifically, there are few related studies available and only data have been reported. The authors in vitro may need more related studies and solid evidence to support their hypothesis to make it more scientific and rigorous. As reported, lithium can be toxic due to its side effects, mainly thyroid, renal, and cognitive and rigorous. As reported, lithium can be toxic due to its side effects, mainly thyroid, renal, and cognitive disturbances. Readers may wish to see more clinical information of lithium in treating viral infection cases, if not available, or in treating other diseases.
In terms of discussion, the authors reviewed some existing literature and suggested a potential mechanism of reduced apoptosis by lithium, the glycogen synthase kinase 3-beta (GSK-3β) inhibitor. The possibility that targeting at GSK-3β by lithium may potentially affect the coronavirus is an interesting topic. However, direct evidence is lacking regarding 2019-nCoV or related coronaviruses including in vitro severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses.
Moreover, relevant literature is still needed although the authors state that there is no interaction between lithium carbonate and ribavirin, lopinavir, or ritonavir exist. Another aspect worth noting is that the authors indicate that monitoring serum lithium concentration can be helpful in preventing side effects of lithium, however it should be emphasized that the relationship between the effective dose and toxic dose in vivo of lithium is still unclear, with some studies reporting a dose-dependent manner of the inhibitory effect of lithium . Thus, it warrants more data, both and , to clarify this issue.
in vitro in vitro in vivo
Collectively, this study proposes a potential role of lithium in treating or preventing 2019-nCoV or NCP with some possible mechanisms. However, by far, solid evidence is lacking to validate this hypothesis. The time of developing lithium orotate for clinical use, even in emergency, is not yet.
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